Progress in Research on the Gut Microflora of the Red Panda (Ailurus fulgens)
Microorganisms · 27.02.2024 · 12 (3) · 478
DOI: 10.3390/microorganisms12030478 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 27.02.2024. Verfasst von Xing Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Liziping Giant Panda's Ecology and Conservation Observation and Research Station of Sichuan Province (Science and Technology Department of Sichuan Pr…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Qinghai-Tibet Plateau Comprehensive Scientific Survey, Innovation Team Funds of China West Normal University.
Abstract (Originalsprache)
Animals can adapt to unique feeding habits through changes in the structure and function of the gut microflora. However, the gut microflora is strongly influenced by the evolutionary relationships between the host, nutritional intake, intake of microorganisms, etc. The red panda (Ailurus fulgens), an herbivorous carnivore, has adapted to consuming bamboo through seasonal foraging strategies and optimization of the composition and function of its gut microflora during long-term evolution. However, to date, studies of the gut bacteria of the red panda have mainly focused on the composition, diversity and function of the gut microflora of captive individuals. There are a lack of studies on how the wild red panda adapts to the consumption of bamboo, which is high in fibre and low in nutrients, through the gut microflora. This paper reviews the technology and methods used in published studies investigating the gut microflora of the red panda, as well as the composition, diversity and function of the identified microbes and the influencing factors. Furthermore, this paper suggests future research directions regarding the methodology employed in analyzing the red panda gut microflora, the interplay between gut microflora and the health of the red panda, the red panda’s adaptation to its gut microflora, and the implications of these studies for the management and conservation of wild red pandas. The goal of this review is to provide a reference for the protection of wild red pandas from the perspective of the gut microflora.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Liziping Giant Panda's Ecology and Conservation Observation and Research Station of Sichuan Province (Science and Technology Department of Sichuan Province), China West Normal University, Nanchong 637001, China.
- Key Laboratory of Southwest China Wildlife Resources Conservation (Ministry of Education), China West Normal University, Nanchong 637002, China.
- Appraisal Center for Environment and Engineering, Ministry of Ecology and Environment, Beijing 100006, China.
ORCID-Profile: Xing Zhao
Förderung
- National Natural Science Foundation of China
- Qinghai-Tibet Plateau Comprehensive Scientific Survey
- Innovation Team Funds of China West Normal University
- Second Qinghai-Tibet Plateau Comprehensive Scientific Survey
- Giant Pandas International Cooperation Foundation of State Forestry Administration (2023)
Zitieren
APA
Zhao, X., Zhang, Z., Wang, L., Zhang, Q., Kang, L., Wang, J., Long, J., & Hong, M. (2024). Progress in Research on the Gut Microflora of the Red Panda (Ailurus fulgens). Microorganisms, 12(3), 478. https://doi.org/10.3390/microorganisms12030478
Vancouver
Zhao X, Zhang Z, Wang L, Zhang Q, Kang L, Wang J, et al. Progress in Research on the Gut Microflora of the Red Panda (Ailurus fulgens). Microorganisms. 2024;12(3):478. doi:10.3390/microorganisms12030478
BibTeX
@article{Zhao2024,
author = {Zhao, Xing and Zhang, Zejun and Wang, Le and Zhang, Qian and Kang, Liwen and Wang, Jia and Long, Juejie and Hong, Mingsheng},
title = {Progress in Research on the Gut Microflora of the Red Panda (Ailurus fulgens)},
journal = {Microorganisms},
year = {2024},
volume = {12},
number = {3},
pages = {478},
doi = {10.3390/microorganisms12030478}
}
EUVIMED